Adaptimmune appoints Christopher Hill as CFO effective September 10, 2025

Adaptimmune Therapeutics PLC

Christopher Hill named CFO via consulting agreement with CJH Financial Limited, effective September 10, 2025.
Hill will receive £2,200/day (approx. $2,968) for CFO services; no bonus or share options.
He steps down as CFO/COO of Istesso Limited on September 9, 2025.
Hill is a chartered accountant with over 10 years of CFO/COO experience in life sciences.
No family relationships or reportable transactions with Adaptimmune.

item 5.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.